Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on January 19, 2004

Circulation. 2004
Published online before print January 19, 2004, doi: 10.1161/01.CIR.0000114521.88547.5E
A more recent version of this article appeared on January 27, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/3/324    most recent
01.CIR.0000114521.88547.5Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemmens, K.
Right arrow Articles by De Keulenaer, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemmens, K.
Right arrow Articles by De Keulenaer, G. W.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Contractile function
Right arrow Heart failure - basic studies

Submitted on August 8, 2003
Revised on December 10, 2003
Accepted on December 11, 2003

Neuregulin-1 Induces a Negative Inotropic Effect in Cardiac Muscle. Role of Nitric Oxide Synthase

Katrien Lemmens MD, Paul Fransen PhD, Stanislas U. Sys MD, PhD, Dirk L. Brutsaert MD, PhD, and Gilles W. De Keulenaer MD, PhD*

From the University of Antwerp, Antwerp, Belgium.

* To whom correspondence should be addressed. E-mail: gilles.dekeulenaer{at}ua.ac.be.

Background--Deficient cardiac neuregulin/ErbB signaling increases susceptibility to heart failure. In this study, we examined the effects of neuregulin-1 (NRG-1) on myocardial contractility.

Methods and Results--NRG-1 ({alpha} and {beta} isoforms) induced a negative inotropic effect in isolated rabbit papillary muscles and a rightward shift of the dose-response curve to isoproterenol. Both effects were attenuated by L-NMMA, which suggests a role for NO synthase. In cultured rat cardiomyocytes, NRG-1{beta} enhanced nitrite production and resulted in phosphorylation of endothelial NO synthase and the serine/threonine kinase Akt.

Conclusions--NRG-1 has negative inotropic effects that are preserved during {beta}-adrenergic stimulation and activates endothelial NO synthase in cardiomyocytes.


Key words: neuregulin • nitric oxide synthase • endothelium • contractility • heart failure




This article has been cited by other articles:


Home page
Circ. Res.Home page
G. Xu, T. Watanabe, Y. Iso, S. Koba, T. Sakai, M. Nagashima, S. Arita, S. Hongo, H. Ota, Y. Kobayashi, et al.
Preventive Effects of Heregulin-{beta}1 on Macrophage Foam Cell Formation and Atherosclerosis
Circ. Res., August 28, 2009; 105(5): 500 - 510.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Ky, S. E. Kimmel, R. N. Safa, M. E. Putt, N. K. Sweitzer, J. C. Fang, D. B. Sawyer, and T. P. Cappola
Neuregulin-1{beta} Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Circulation, July 28, 2009; 120(4): 310 - 317.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Lemmens, K. Doggen, and G. W. De Keulenaer
Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease: Implications for Therapy of Heart Failure
Circulation, August 21, 2007; 116(8): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Y. Chung and J. W. Walker
Interaction and Inhibitory Cross-Talk between Endothelin and ErbB Receptors in the Adult Heart
Mol. Pharmacol., June 1, 2007; 71(6): 1494 - 1502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Lemmens, V. F. M. Segers, M. Demolder, and G. W. De Keulenaer
Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk
J. Biol. Chem., July 14, 2006; 281(28): 19469 - 19477.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M.-N. Giraud, M. Fluck, C. Zuppinger, and T. M. Suter
Expressional reprogramming of survival pathways in rat cardiocytes by neuregulin-1{beta}
J Appl Physiol, July 1, 2005; 99(1): 313 - 322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Lemmens, V. F.M. Segers, G. W. De Keulenaer, K. Okoshi, M. Nakayama, X. Yan, M. P. Okoshi, A. J.T. Schuldt, B. H. Lorell, and M. A. Marchionni
Letter Regarding Article by Okoshi et al, "Neuregulins Regulate Cardiac Parasympathetic Activity: Muscarinic Modulation of {beta}-Adrenergic Activity in Myocytes From Mice With Neuregulin-1 Gene Deletion" * Response
Circulation, April 5, 2005; 111(13): e175 - e175.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H. Ueda, A. Oikawa, A. Nakamura, F. Terasawa, K. Kawagishi, and T. Moriizumi
Neuregulin Receptor ErbB2 Localization at T-tubule in Cardiac and Skeletal Muscle
J. Histochem. Cytochem., January 1, 2005; 53(1): 87 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kuramochi, G. M. Cote, X. Guo, N. K. Lebrasseur, L. Cui, R. Liao, and D. B. Sawyer
Cardiac Endothelial Cells Regulate Reactive Oxygen Species-induced Cardiomyocyte Apoptosis through Neuregulin-1{beta}/erbB4 Signaling
J. Biol. Chem., December 3, 2004; 279(49): 51141 - 51147.
[Abstract] [Full Text] [PDF]